-
news · 24 Jun 2026
x-tosis lands a $2.74M Michael J. Fox Foundation grant to push XTS001 — a brain-penetrant VDAC1-oligomerization blocker — toward Parkinson's
The most conflicted post on the site, flagged as such: x-tosis — the biotech I co-founded — just won a $2.74M grant from The Michael J. Fox Foundation to advance XTS001, an oral, brain-penetrant molecule that blocks VDAC1 oligomerization, into Parkinson's development.
